HAZ Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Haemonetics Corp

Watchlist Manager

Watchlist

Price: 92 EUR -1.6%

Market Cap: €2.8B

H	Haemonetics Corp XMUN:HAZ	US
L	Level Biotechnology Inc TPEX:3118	TW
	Shattuck Labs Inc NASDAQ:STTK	US
S	Sarine Technologies Ltd OTC:SILLF	IL
G	Genesys Logic Inc TPEX:6104	TW

Profitability Summary

Haemonetics Corp's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

59%

Strong 3Y Average Gross Margin

56%

Gross Margin is Increasing

53% > 59%

Healthy Operating Margin

18%

Sustainable 3Y Average Operating Margin

17%

Operating Margin is Increasing

15% > 18%

Low Net Margin

Sustainable 3Y Average Net Margin

10%

Declining Net Margin

10% > 7%

Exceptional Free Cash Flow Margin

18%

Strong 3Y Average Free Cash Flow Margin

11%

Free Cash Flow Margin is Increasing

16% > 18%

Positive ROE

12%

Positive 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.